Donation

The International Myeloma Foundation brings myeloma support group leaders and patients to the annual meeting of the American Society of Hematology (ASH), an exciting convergence of over 30,000 health care professionals from around the world. Start following the IMF ASH team members now on social media as they ramp up to share the latest clinical updates in myeloma research, therapies, and practice strategies via X(formerly Twitter), Facebook, blogs, and videos.

Watch the 2025 ASH Meeting Facebook Live Replay
See Our Coverage On Social Media

Meet the Team
Myeloma patient Sheri Baker
Sheri Baker

Sheri was diagnosed at age 49 with kidney failure and myeloma.  Her prognosis was 3-5 years, and she thought she would never see her children get married or have grandchildren.  She is proud to be a 14-year Multiple Myeloma survivor.  She has been married for 41 years, has 3 children and 2 grandchildren.    

Motivated by her desire to help other patients and care partners, Sheri established the Treasure Valley Multiple Myeloma Support Group in Meridian, Idaho in 2017.  She is grateful for her husband Jim, who supports her efforts in being a patient advocate.  

This is the seventh time that Sheri will be attending the ASH, and she will focus on treatment options for relapsed/refractory patients, especially those with renal impairment.

Follow Sheri on X: @blondie1746 
Support Group Website: Treasure Valley Multiple Myeloma Support Group 

b
Image Left
White
Becky Bosley
Becky Bosley, BSN, RN

Becky has been an oncology nurse since 2006, including professional roles as an inpatient bedside nurse, healthcare informatics, as well as Transplant Nurse Coordinator, navigating myeloma patients through the transplant process, and for the last eight years, has primarily focused on myeloma.  Since 2018, she has led the MidAtlantic Myeloma Support Group and co-leads the Living with High-Risk Myeloma virtual special interest group, which she founded in 2023.  

Passionate about empowering patients with education, she leverages her oncology nursing expertise to support myeloma patients and their care partners. As a breast and ovarian cancer survivor, she brings a deeply personal understanding of the challenges faced by those diagnosed with cancer.

Her professional role at the IMF includes educationally supporting Support Groups across the MidAtlantic region of the US. Becky lives in Pennsylvania with her large, blended family and values her quality time with them, including being actively involved in her children’s soccer, baseball, and volleyball activities. 

Follow Becky on X: @MidAtlanticMSG 
Support Group Website: Mid-Atlantic Myeloma Support And Information Group and Living with High-Risk Multiple Myeloma Support Group

 

b
Image Left
White
Jessie Daw
Jessie Daw

Jessie Daw was diagnosed with smoldering myeloma (SMM) in late 2016 after numerous respiratory infections. While the status of her condition allows for treatment, she has embraced an “active surveillance” approach with careful monitoring while leading an active and fulfilling life. Jessie works in higher education, where she is the chair of the Kinesiology & Sports Management Division at USD.  

Her personal experience with SMM motivated her to co-found/lead Smolder Bolder, a virtual special interest support group for individuals with SMM. She is also a co-founder/leader of the Eastern South Dakota Multiple Myeloma Support Group.  

This will be her fifth time attending ASH, where she stays up to date with the latest advancements in SMM.

Read Jessie's Dec. 5th blog from ASH: "Highlights from the Friday Satellite Symposiums at ASH."

Read Jessie's Post-ASH 2025 blog: "Understanding MGUS, Smoldering Myeloma, and Active Myeloma: A Patient's Perspective from ASH 2025."

Follow Jessie on X: @Daw6Jessie 
Support Group Website: Eastern South Dakota Multiple Myeloma Support Group  and Smolder Boulder 

b
Image Left
White
Mindy C. Fast
Mindy C. Fast

Mindy C. Fast was diagnosed with multiple myeloma in early 2007. She has journeyed through auto and allogenic transplants, too much chemo and immunotherapies, radiation, and CAR T-cell therapy.  At this point, Mindy has been MRD Negative for almost two and a half years.  Mindy is passionate about advocating for patients with multiple myeloma and their caregivers to help improve the quality of their lives.

Mindy finds inspiration, support, and joy in her dear family, healthcare team, friends, and fellow myeloma advocates. Mindy co-founded and co-leads a local multiple myeloma support group. Next week you might find Mindy working out at the Y, volunteering at Massey Comprehensive Cancer Center, watching her backyard birds, playing Mah Jongg with friends, or hanging with her granddaughter.

Follow Mindy on X: @myelomaMindy  
Support Group Website: Greater Richmond Multiple Myeloma Support Group   

b
Image Left
White
Terry Glassman
Terry Glassman

Terry was diagnosed with high-risk Multiple Myeloma/Primary Plasma Cell Leukemia in November 2022. She is currently in strong remission and has had her stem cells harvested, though she has not yet undergone a transplant.

A registered nurse with a background in ICU and cardiac care, Terry feels her medical training has helped her better understand the complexities of this difficult diagnosis. Still, despite having a strong support system, the early days of her journey were very challenging. This experience deepened her empathy and fueled her commitment to helping other patients navigate their own myeloma journeys.

In July 2024, Terry founded the Long Island Support Group and also joined Becky Bosley as co-leader of the High-Risk Multiple Myeloma Group in 2025. Terry is a returning voice at ASH and is excited to learn more and share it with her fellow MM patients.

Read Terry's Post-ASH Blog, "From Abstracts to Hope: What ASH Means for Myeloma Patients."

Follow Terry on X: @TerryGlassman 
Support Group Website: Long Island Multiple Myeloma Informational Support Group and Living with High-Risk Multiple Myeloma Support Group 

b
Image Left
White
Diane Hunter
Diane Hunter

Diane is a support group co-leader for the Montgomery Area Multiple Myeloma Networking Group. She holds a Bachelor of Science in Business Administration from Wayne State University and retired after 35 years with General Motors and Electronic Data Systems (now HP).

Since retirement, she has devoted herself to what she calls her “heart’s work”—supporting others, cooking, and spending time with her family. She lives in Montgomery, Alabama, and has served as Chef-Cook at the Moss Hammock Hunting Preserve for nine years.

Diagnosed with multiple myeloma in 2017, she underwent a successful autologous stem cell transplant the same year and remains in stringent remission. Her experiences have deepened her commitment to addressing disparities in healthcare for Black and elderly patients.

She completed the IMF and Patients Rising Master Class in Patient Advocacy in 2024 and began advocating on Capitol Hill in 2025. Her mission is to inspire hope, resilience, and confidence in fellow myeloma patients and care partners as treatments continue to advance and outcomes improve.

Follow Diane on Facebook:  Diane Hunter
Support Group Website: Montgomery Area Support Group 

b
Image Left
White
Teresa Miceli
Teresa Miceli RN, BSN, OCN

Teresa Miceli is a registered nurse at Mayo Clinic-Rochester, MN. She is a recognized key opinion leader in the care of people living with multiple myeloma.  Teresa is an originating member of the IMF’s Nurse Leadership Board and has spent over 30 years providing care to people undergoing Blood and Marrow Transplantation (BMT). Her passion for patient empowerment, education and helping people to navigate the health care system led her to develop the Myeloma Nurse Navigator role at Mayo Clinic in 2021. In 2023, she was appointed to the National Cancer Institute’s Myeloma Steering Committee as a patient advocate.

Follow Teresa on X: @IMFnurseMYELOMA 
Support Group Website: Multiple Myeloma Sharing Sessions and Smolder Bolder 

b
Image Left
White
Rob Salmon
Rob Salmon

Rob was diagnosed with Multiple Myeloma in 2020. Rob had a transplant in 2021 and is now on maintenance therapy. At the end of 2022, Jack Aiello asked Rob to co-lead the SF Bay Area Multiple Myeloma Support Group with him.  

Rob is a retired executive from the technology industry. Today, he is still actively advising start-up companies in technology. Rob is married and has two adult children.  

Since being diagnosed, Rob and his wife Patty have met wonderful people on this journey. Doctors, nurses, people at non-profit organizations focused on Multiple Myeloma, and other patients are all on the same team - working towards a brighter future for those with Multiple Myeloma.  

Follow Rob on X: @Salmon_Rob 
Support Group Website: SF Bay Area MM Support Group 

b
Image Left
White
Jim Shoemaker
Jim Shoemaker

Diagnosed in 2007 at 59, Jim has had various treatments, including transplant and recently, a clinical trial with Talquetamab. Jim founded the Memphis group and is passionate about supporting the myeloma community. Having a solid support system at home, with his best friend, wife of over 50 years, and care partner, Linda has provided Jim strength when he needed it most. To say she is the “best” would be an understatement.  

Jim works full-time & is very involved with his church-Jim shares that exercise, diet, and prayer make a difference. Jim says, “I have been a student of this disease for many years now and I feel God has called me to be a small part in helping others navigate this process and encouraging them to be their best advocates.”  

Follow Jim on X: @JimJhs17 
Support Group Website: The Memphis/Mid-South Multiple Myeloma Support Group 

b
Image Left
White
Rose Simon
Rose Simon

In 2023, Rose visited her local orthopedic doctor after suspecting she might have injured her back while working out. What she believed would be a routine follow-up appointment quickly changed course when scans revealed a diagnosis of Multiple Myeloma — a type of cancer she had never heard of before. Overnight, she found herself navigating a whirlwind of doctor’s appointments and treatment plans, all while trying to determine the best path forward.

Fortunately, Rose was surrounded by a compassionate team of physicians who took the time to explain each step of her treatment journey. She also discovered her local Maitland Multiple Myeloma Support Group, which she credits with helping her understand that a full and meaningful life is still possible after diagnosis.

In March 2024, Rose underwent a successful stem cell transplant and is now in remission. Today, she is passionate about supporting others facing similar challenges. She wants every patient to know that while the road may feel overwhelming at first, there are many resources available — and no one has to go through this alone.

Follow Rose on 

Support Group Site: Maitland FL Multiple Myeloma Support Group

 

b
Image Left
White
Michael Tuohy
Michael Tuohy

Michael Tuohy was diagnosed with multiple myeloma in 2000. With two young children (ages 2 and 7) the focus was always on seeking out the best treatment options, myeloma experts, and beating myeloma. Michael has seen many silver linings in life and is grateful for continued interest and research in myeloma. His approach over the years has been to become empowered, engaged and educated to have better conversations with his own healthcare team and to share his experience and hope with others.  

Follow Michael on X: @IMFmikeMYELOMA 
Support Group Website: Connecticut Multiple Myeloma Fighters Information Group 

b
Image Left
White
Robin Tuohy
Robin Tuohy

Robin Tuohy became a passionate advocate in 2000 when her husband, Michael was diagnosed with multiple myeloma. In 2005 she began working for the International Myeloma Foundation and is now Vice President, Patient Support. Robin attends most major myeloma medical meetings, IMF Patient & Family Seminars and Regional Community Workshops to stay up to date and to share the information and hope with other myeloma patients and care partners. Robin leads the IMF’s Support Group Team and oversees approximately 155 U.S. myeloma specific support groups.  

Follow Robin on X: @IMFsupport 
Support Group Websites: Connecticut Multiple Myeloma Fighters Information Group and Care Partners Only Special Interest Group

 

b
Image Left
White
Jenn Wieworka
Jenn Wieworka DNP, RN, OCN

Jenn has been an oncology nurse for 13 years.  She is passionate about addressing health disparities, quality improvement, and the importance of continued learning.  Jenn has her Doctorate of Nursing Practice, is a Director, Support Groups with the IMF, and co-leads the Veterans with Myeloma Special Interest Group. Last year, Jenn attended ASH for the first time in person and will be leading the Myeloma Voices at ASH team Virtually.  

Follow Jenn on X: @JWiework

Support Group Website: The Veterans with Myeloma Special Interest Group

b
Image Left
White
Eric Wolf
Eric Wolf

Eric was diagnosed with multiple myeloma in 2012 at the age of 46, during the 28th year of his career as a United States Marine. Since then, he has faced many ups and downs — including surgery, radiation, multiple lines of therapy, and two stem cell transplants — but has also been uplifted by the love and support of family, friends, fellow patients, and cancer allies.

Motivated by his hard-won experiences, deep compassion, and sense of calling, Eric connects daily with patients both within and beyond his network. His strength lies in the human, person-to-person touch, and he currently co-leads the Upland and San Gabriel Valley, CA support groups.

Eric has been married to his high school sweetheart for 40 years. Together, they have four grown children and a granddaughter. He enjoys hiking, motorcycle riding, and helping others find hope on their myeloma journey.

Follow Eric on X: @EricWolf_USMC 
Support Group Website: Upland CA Multiple Myeloma Support Group 

b
Image Left
White
Jill Zitzewitz
Jill Zitzewitz, PhD

Jill Zitzewitz, PhD is an associate professor in academic medicine where she has spent her career studying protein misfolding diseases. Since being diagnosed with MM in 2017, Jill has been teaching medical students and graduate students and using her experience to provide the patient perspective to future doctors and scientists.  In 2020, Jill became the leader for the Central MA Multiple Myeloma Support Group, and she recently had CAR-T cellular therapy to get her MM back under control after a second relapse. Jill's four children were teenagers when she was diagnosed, and she’s grateful that her various myeloma therapies have allowed her to continue working and to be present for her family. For her 5th ASH experience, Jill plans to use her background in science and education to help other patients understand the impact of new and novel therapies for treating MM.    

Read Jill Zitzewitz's blog on the Satellite Symposia from Day 1 of ASH 2025: "The Fast Pace of Progress in Myeloma Treatment Practice"

Follow Jill on Bl;uesky: @jillzzz.bsky.social
Support Group Website: Central MA Multiple Myeloma Support Group 

b
Image Left
White
See Previous Year's Coverage
Banner of Support Group Leaders at the 2024 American Society of Hematology Annual Meeting
ASH 2024 - San Diego

IMF Support Group Leaders have their fingers on the pulse of ASH 2024. Read their experiences during the 66th Annual ASH meeting.

a
Image Left
White
Our bone marrow creates plasma cells that make antibodies, which play an important role in fighting off viruses and bacteria. Multiple myeloma causes the bone marrow to create dysfunctional antibodies and plasma cells. A malignant plasma cell or cancer cell is referred to as a myeloma cell.

Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.
Our bone marrow creates plasma cells that make antibodies, which play an important role in fighting off viruses and bacteria. Multiple myeloma causes the bone marrow to create dysfunctional antibodies and plasma cells. A malignant plasma cell or cancer cell is referred to as a myeloma cell.

Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.

The content appearing on this page is not provided by the IMF. The IMF neither warrants nor guarantees the accuracy of such content. The forgoing notwithstanding, the content is not a substitute for advice and service provided by qualified and licensed medical professionals and should not be relied on with respect to any health matters. Any health-related information found herein is only made available as part of a general educational service.

Thank You to Our Sponsors:
AbbVie Logo
gsk logo 2022
Johnson and Johnson
Karyopharm logo
Regeneron logo
Sanofi logo

Give Where Most Needed